MeSH tree: N05.715.360.575.575.800.190
The U.S. Food and Drug Administration has approved Merck's Welireg (belzutifan) in combination with pembrolizumab or pembrolizumab and berahyaluronidase alfa-pmph (Keytruda Qlex) for the adjuvant treatment of renal cell carcinoma ...
Jun 19, 2026
0
6
A new Northwestern Medicine study suggests that a simple blood test could help identify which patients with head and neck cancer will be most likely to benefit from immunotherapy, according to a study published in the Journal ...
Jun 8, 2026
0
3
Results of a multicenter clinical trial found that adding the investigational adenoviral-based viral immunotherapy aglatimagene besadenovec (alglatimagene, CAN-2409) to standard radiation therapy improved disease-free survival ...
Jun 2, 2026
0
27
A blood test could help doctors decide which patients with colon cancer should receive anti-inflammatory medication along with chemotherapy after surgery, according to a study appearing in JAMA Oncology. Based on data from ...
Dec 15, 2025
0
11
Using a gene signature technique to tailor chemotherapy for patients with early triple negative breast cancer shows promise as a way to improve disease-free survival, finds a clinical trial published by The BMJ today.
Oct 23, 2024
0
28
